Mifepristone: A potential contraceptive

Clinical Obstetrics and Gynecology

Volumn 39, Issue 2, 1996, Pages 461-468

  Heikinheimo, Oskari ^a,c   Archer, David F ^b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE;

DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HORMONAL REGULATION; HORMONE INHIBITION; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; LUTEAL PHASE; MONKEY; NONHUMAN; ORAL CONTRACEPTION; OVULATION INHIBITION; REVIEW;

BIOLOGY; CONTRACEPTION; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE AGENTS, POSTCOITAL; CONTRACEPTIVE MODE OF ACTION; ENDOCRINE EFFECTS; ENDOCRINE SYSTEM; ENDOMETRIAL EFFECTS; ENDOMETRIUM; FAMILY PLANNING; GENITALIA; GENITALIA, FEMALE; HORMONE ANTAGONISTS; HORMONES; LITERATURE REVIEW; OVULATION SUPPRESSION; PHYSIOLOGY; RU-486--ADMINISTRACTION AND DOSAGE; RU-486--SIDE EFFECTS; RU-486--THERAPEUTIC USE; UROGENITAL SYSTEM; UTERUS;

CONTRACEPTIVE AGENTS; CONTRACEPTIVES, POSTCOITAL; ENDOMETRIUM; FEMALE; HUMANS; MENSTRUATION-INDUCING AGENTS; MIFEPRISTONE; OVULATION;

EID: 0029934732     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-199606000-00019     Document Type: Review

References (20)

1. Lähteenmäki P, Rapeli T, Kääriäinen M, Alfthan H, Ylikorkala O. Late postcoital treatment against pregnancy with antiprogesterone RU 486. Fertil Steril. 1988;50:36-38.
2. Couzinet B, Le Strat N, Silvestre L, Schaison G. Late luteal administration of the antiprogesterone RU 486 in normal women: effects on the menstrual cycle events and fertility control in a long-term study. Fertil Steril. 1990;54:1039-1044.
3. Gemzell-Danielsson K, Swahn M-L, Svalander P, Bygdeman M. Early luteal phase treatment with mifepristone (RU 486) for fertility regulation. Hum Reprod. 1993;8: 870-873.
4. Glasier A, Thong K, Dewar M, Mackie M, Baird D. Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception. New Engl J Med. 1992;327:1041-1044.
5. Webb A, Russell J, Elstein M. Comparison of Yuzpe regimen, danazol, and mifepristone (RU 486) in oral postcoital contraception. BMJ. 1992;305:927-931.
6. Luukkainen T, Heikinheimo O, Haukkamaa M, Lähteenmäki P. Inhibition of folliculogenesis and ovulation by the antiprogesterone RU 486. Fertil Steril. 1988;49:961-963.
7. Liu J, Garzo G, Morris S, Stuenkel C, Ulmann A, Yen S. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU 486. J Clin Endocrinol Metab. 1987;65: 1135-1140.
8. Ledger W, Sweeting V, Hillier H, Baird D. Inhibition of ovulation by low dose mifepristone (RU 486). Hum Reprod. 1992;7: 945-950.
9. Croxatto H, Salvatierra AM, Croxatto H, Fuentealba B. Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle. Hum Reprod. 1993;8: 201-207.
10. Kekkonen R, Lähteenmäki P, Luukkainen T, Tuominen J. Sequential administration of the antiprogesterone RU 486 and synthetic progestin for contraception. Fertil Steril. 1993;60:610-615.
11. Kettel M, Liu J, Murphy A, Ulmann A, Mortola J, Yen S. Endocrine responses to long-term administration of the antiprogesterone RU 486 in patients with pelvic endometriosis. Fertil Steril. 1991;56:402-407.
12. Batista M, Cartledge T, Zellmer A, Merino M, Axiotis C, Loriaux L, Nieman L. Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy. Am J Obstet Gynecol. 1992;167:60-65.
13. Spitz I, Croxatto H, Salvatierra A-M, Heikinheimo O. Response to intermittent RU 486 in women. Fertil Steril. 1993;59:971-975.
14. Kekkonen R, Croxatto H, Lähteenmäki P, Salvatierra AM, Tuominen J. Effects of intermittent antiprogestin RU 486 combined with cyclic medroxyprogesterone acetate on folliculogenesis and ovulation. Hum Reprod. 1995;10:287-292.
15. Heikinheimo O, Gordon K, Lähteenmäki P, Williams R, Hodgen G. Antiovulatory actions of RU 486 - pituitary is not a primary site of antiprogestin action in vivo. J Clin Endocrinol Metab. 1995;80:1859-1868.
16. Batista M, Cartledge T, Zellmer A, Nieman L, Loriaux L, Merriam G. The antiprogestin RU 486 delays the midcycle gonadotropin surge and ovulation in gonadotropin-releasing hormone-induced cycles. Fertil Steril. 1994;62:28-34.
17. Greene K, Kettel M, Yen S. Interruption of the endometrial maturation without hormonal changes by an antiprogesterone during the first half of luteal phase of the menstrual cycle: a contraceptive potential. Fertil Steril. 1992;58:338-343.
18. Gemzell-Danielsson K, Westlund P, Johannisson E, Swahn M-L, Bygdeman M, Seppälä M. Effect of low weekly doses of mifepristone on ovarian function and endometrial development. Hum Reprod. (In press).
19. Murphy A, Kettel M, Morales A, Roberts V, Parmley T, Yen S. Endometrial effects of long-term low-dose administration of RU 486. Fertil Steril. 1995;63:761-766.
20. World Health Organization task force on post-ovulatory methods of fertility regulation. Menstrual regulation by mifepristone plus prostaglandin: results from multicenter trial. Hum Reprod. 1995;10:308-314.